Skip to main content (Press Enter).
How will clinical guidelines and pathways change how oncology care is delivered and how costs are managed? Dr. Mark Green (Chief Medical Officer) and Doug Neely (Senior Director) of Xcenda discuss this important topic.
Dr. Mark Green is chief medical officer of Xcenda, where he collaborates with manufacturers to gather strategic insight into how and why medical providers make the choices they do relative to patient treatment. Dr. Green leads the Network for Oncology Communication and Research (NOCR), a nationally represented group of nearly 8,000 academic, hospital, and community-based oncologists and hematologists as well as more than 1,600 mid-level providers and oncology nurses.
Prior to joining Xcenda in 2007, Dr. Green was medical director for the Network for Medical Communication and Research and a clinical professor of medicine at the Medical University of South Carolina. Previously, he held numerous faculty positions at the University of California San Diego School of Medicine.
Dr. Green received his undergraduate and medical degrees from Harvard University and did post-graduate training at the Beth Israel Hospital in Boston, the National Cancer Institute and Stanford University.
Xcenda
Dec 11, 2011
May 18, 2010
May 22, 2012
Jan 10, 2012